Sphera Funds Management Ltd. Kymera Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $5.2 Million - $15.7 Million	-368,061 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $1.74 Million - $3.19 Million	49,394 Added 15.5%	368,061 $15.6 Million
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $2.03 Million - $2.66 Million	-40,593 Reduced 11.3%	318,667 $20.2 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $4.75 Million - $6.62 Million	99,365 Added 38.23%	359,260 $21.1 Million
Q2 2021 Aug 17, 2021	BUY	$31.08 - $51.95 $384,397 - $642,517	12,368 Added 5.0%	259,895 $12.6 Million
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $3.56 Million - $8.53 Million	99,827 Added 67.59%	247,527 $9.62 Million
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $345,261 - $1.08 Million	-12,300 Reduced 7.69%	147,700 $9.16 Million
Q3 2020 Nov 12, 2020	BUY	$26.1 - $33.28 $4.18 Million - $5.32 Million	160,000 New	160,000 $5.17 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.